A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
NCT ID: NCT03495102
Last Updated: 2020-06-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1842 participants
INTERVENTIONAL
2018-04-05
2019-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
NCT02597049
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
NCT02973100
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
NCT05659537
A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
NCT05144984
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
NCT02111096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dulaglutide 1.5 mg
Dulaglutide 1.5 mg administered subcutaneously (SC) once a week.
Dulaglutide
Administered SC
Dulaglutide 3 mg
Dulaglutide 3 mg administered SC once a week.
Dulaglutide
Administered SC
Dulaglutide 4.5 mg
Dulaglutide 4.5 mg administered SC once a week.
Dulaglutide
Administered SC
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dulaglutide
Administered SC
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have been treated with stable metformin dose for at least 3 months
* Have HbA1c ≥7.5% and ≤11.0% at study entry
* Have body mass index (BMI) ≥25 kilograms per meter squared (kg/m\^2)
Exclusion Criteria
* Have used any glucagon-like peptide-1 receptor agonist (GLP-1 RA) or insulin, not including prior short term insulin use (≤14 days)
* Have been taking any other medicine for diabetes (other than metformin) during the last 3 months
* Have used in the last 3 months (or plan to use) prescription weight loss medications
* Have disorders associated with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
* Current participation in or intent to begin during the study an organized diet and/or exercise weight reduction program (other than the lifestyle and dietary measures for diabetes)
* Have acute or chronic hepatitis, signs and symptoms of any other liver disease other than nonalcoholic fatty liver disease (NAFLD), or alanine transaminase (ALT) level \>2.5 times the upper limit of the reference range, as determined by the central laboratory at study entry; participants with NAFLD are eligible for participation in this trial
* Had chronic or acute pancreatitis any time prior to study entry
* Have had a heart attack or stroke in the past 2 months, or have heart failure that significantly limits their physical activity
* Estimated glomerular filtration rate (eGFR) \<30 milliliters/minute/1.73m\^2 (or lower than the country-specific threshold for discontinuing metformin therapy per local label), calculated by the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, as determined by the central laboratory at study entry and confirmed at lead-in
* Have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2
* Have proliferative retinopathy or maculopathy requiring acute treatment according to the opinion of the investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eli Lilly and Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Role: STUDY_DIRECTOR
Eli Lilly and Company
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Synexus- Chandler
Chandler, Arizona, United States
Synexus/Central Arizona Medical Associates, PC
Mesa, Arizona, United States
Central Phoenix Med Clinic LLC
Phoenix, Arizona, United States
Arkansas Clinical Research
Little Rock, Arkansas, United States
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Valley Research
Fresno, California, United States
National Research Institute
Huntington Park, California, United States
National Research Institute
Los Angeles, California, United States
Catalina Research Institute, LLC
Montclair, California, United States
Valley Clinical Trials, Inc.
Northridge, California, United States
Pacific Research Partners, LLC
Oakland, California, United States
National Research Institute
Panorama City, California, United States
Sierra Clinical Research
Roseville, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
Care Access Research
Santa Clarita, California, United States
Encompass Clinical Research
Spring Valley, California, United States
University Clinical Investigators, Inc.
Tustin, California, United States
Diablo Clinical Research
Walnut Creek, California, United States
Chase Medical Research, LLC
Waterbury, Connecticut, United States
ALL Medical Research, LLC
Cooper City, Florida, United States
Clinical Research of South Florida
Coral Gables, Florida, United States
Suncoast Research Group, LLC
Miami, Florida, United States
New Horizon Research Center
Miami, Florida, United States
Oviedo Medical Research
Oviedo, Florida, United States
Urban Family Practice Associates, PC
Marietta, Georgia, United States
In-Quest Medical Research, LLC- Peachtree Corners
Peachtree Corners, Georgia, United States
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii, United States
East West Medical Institute
Honolulu, Hawaii, United States
Elite Clinical Trials LLLP
Blackfoot, Idaho, United States
Saltzer Medical Group. P.A.
Nampa, Idaho, United States
Prairie Education and Research Cooperative
Springfield, Illinois, United States
Synexus/Clinical Research Advantage
Evansville, Indiana, United States
Midwest Institute for Clinical Research
Indianapolis, Indiana, United States
Iderc, P.L.C.
West Des Moines, Iowa, United States
InterMed, PA
Portland, Maine, United States
MedStar Health Research Institute
Hyattsville, Maryland, United States
NECCR PrimaCare Research, LLC
Fall River, Massachusetts, United States
Aa Mrc Llc
Flint, Michigan, United States
Troy Internal Medicine, PC
Troy, Michigan, United States
Clinical Research Professionals
Chesterfield, Missouri, United States
StudyMetrix Research, LLC
City of Saint Peters, Missouri, United States
Montana Health Research
Billings, Montana, United States
Glacier View Research Institute
Kalispell, Montana, United States
Premier Research
Trenton, New Jersey, United States
Manhattan Medical Research
New York, New York, United States
Great Lakes Medical Research
Westfield, New York, United States
Metrolina Internal Medicine, P.A.
Charlotte, North Carolina, United States
Diabetes & Endocrinology Consultants PC
Morehead City, North Carolina, United States
Aventiv Research
Columbus, Ohio, United States
Intend Research
Norman, Oklahoma, United States
IPS Research Company
Oklahoma City, Oklahoma, United States
The Corvallis Clinic P.C.
Corvallis, Oregon, United States
Summit Research Network Inc
Portland, Oregon, United States
Heritage Valley Medical Group, Inc.
Beaver, Pennsylvania, United States
Detweiler Family Medicine
Lansdale, Pennsylvania, United States
Preferred Primary Care Physicians
Pittsburgh, Pennsylvania, United States
Sudir Bansal M.D. Inc.
Warwick, Rhode Island, United States
PMG Research of Charleston, LLC
Moncks Corner, South Carolina, United States
Chattanooga Research and Medicine (CHARM)
Chattanooga, Tennessee, United States
Dallas Diabetes Endocrine Center
Dallas, Texas, United States
Southern Endocrinology and Associates PA
Mesquite, Texas, United States
Consano Clinical Research
Shavano Park, Texas, United States
Martin Diagnostic Clinic
Tomball, Texas, United States
ClinPoint Trials, LLC
Waxahachie, Texas, United States
Progressive Clinical Research
Bountiful, Utah, United States
Advanced Research Institute
Ogden, Utah, United States
Manassas Clinical Research Center
Manassas, Virginia, United States
Clinical Research Partners, LLC
Richmond, Virginia, United States
Capital Clincial Research Center
Olympia, Washington, United States
Walla Walla Clinic
Walla Walla, Washington, United States
Wenatchee Valley Hospital & Clinics
Wenatchee, Washington, United States
Prevea Clinic, Inc
Green Bay, Wisconsin, United States
Centro Medico CICEMO
Caba, Buenos Aires, Argentina
CEDIC-Centro de Investigaciones Clinicas
Caba, Buenos Aires, Argentina
Investigaciones Medicas IMOBA S.R.L.
Caba, Buenos Aires, Argentina
Centro de Investigaciones Metabólicas (CINME)
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
Centro de Investigacion y Prevencion Cardiovascular (CIPREC)
Ciudad Autonoma de, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, Buenos Aires, Argentina
CIPADI
Godoy Cruz, Mendoza Province, Argentina
AXISMED SRL - Bioclinica Research Network
Buenos Aires, , Argentina
CENUDIAB
Ciudad Autonoma de Buenos Aire, , Argentina
Centro Médico Viamonte
Ciudad Autonoma de Buenos Aire, , Argentina
Instituto Centenario
Ciudad Autonoma de Buenos Aire, , Argentina
Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
Ciudad Autonoma de Buenos Aire, , Argentina
Mautalen Salud e Investigación - Servicio de Endocrinología
Ciudad Autonoma de Buenos Air, , Argentina
Instituto Medico Strusberg
Córdoba, , Argentina
Centro Medico Privado San Vicente Diabetes
Córdoba, , Argentina
Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC
Córdoba, , Argentina
Landesklinikum Korneuburg-Stockerau, Standort Stockerau
Stockerau, Lower Austria, Austria
Universitätsklinikum Graz
Graz, Styria, Austria
Ordination Dr. Evelyn Fließer-Görzer
Saint Stefan Ob Stainz, Styria, Austria
VIVIT Institut am LKH Feldkirch
Feldkirch, Vorarlberg, Austria
KA Rudolfstiftung
Vienna, , Austria
Zentrum für klinische Studien Dr. Ursula Hanusch GmbH
Vienna, , Austria
Bailey Clinic
Red Deer, Alberta, Canada
Aggarwal and Associates Ltd
Brampton, Ontario, Canada
T. Nemtean Medicine Professional Corporation
Mississauga, Ontario, Canada
Bluewater Clinical Research Group Inc
Sarnia, Ontario, Canada
Stayner Medical Clinic
Stayner, Ontario, Canada
Dr. Anil K. Gupta Medicine Professional Corporation
Toronto, Ontario, Canada
Iatriko Palaiou Falirou, Medical Center
Palaió Fáliro, Athens, Greece
Laiko General Hospital of Athens
Ampelokipoi, Attica, Greece
Gen Hospital of Athens G Gennimatas
Athens, Attica, Greece
G.Papanikolaou General Hospital
Eksochi, Thessaloniki, Greece
Thermi Clinic
Thermi, Thessaloniki, Greece
Athens Euroclinic
Athens, , Greece
University General Hospital of Larissa
Larissa, , Greece
AHEPA Hospital
Thessaloniki, , Greece
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, , Greece
Euromedica - General Clinic of Thessaloniki
Thessaloniki, , Greece
Studium Egeszseghaz Kft.
Kalocsa, Bács-Kiskun county, Hungary
Kenezy Gyula Korhaz es Rendelointezet
Debrecen, Hajdú-Bihar, Hungary
Grof Esterhazy Korhaz es Rendelointezeti Szakrendelo
Pápa, Veszprém megye, Hungary
Szent Margit Rendelointezet
Budapest, , Hungary
ClinDiab Kft.
Budapest, , Hungary
Strazsahegy Medicina Bt.
Budapest, , Hungary
TRANTOR 99 Bt.
Budapest, , Hungary
Kanizsai Dorottya Korhaz
Nagykanizsa, , Hungary
Zala Megyei Szent Rafael Korhaz
Zalaegerszeg, , Hungary
Maccabi Diabetes Clinic, Grand Canyon, North District, Haifa
Haifa, , Israel
Linn Medical Center
Haifa, , Israel
Hadassah Medical Center
Jerusalem, , Israel
Meir Medical Center
Kfar Saba, , Israel
Clalit Health Services - Shuali Clinic
Raanana, , Israel
ZIV Medical Center
Safed, , Israel
Sakhnin Community Clinic, Clalit Health Services
Sakhnin, , Israel
Diabetes Medical Center (DMC)
Tel Aviv, , Israel
Tel Aviv Sourasky Medical Center
Tel Aviv, , Israel
Azienda Ospedaliera Universitaria Careggi
Florence, Florence, Italy
Istituto Clinico Humanitas
Rozzano, Milano, Italy
A.O.U. Senese Policlinico Santa Maria alle Scotte
Siena, SI, Italy
Azienda Ospedaliera Papa Giovanni XXIII
Bergamo, , Italy
Policlinico Mater Domini
Catanzaro, , Italy
Fondazione Universitaria degli Studi G D'Annunzio
Chieti, , Italy
Ospedale Santa Maria Goretti
Latina, , Italy
Policlinico Giaccone
Palermo, , Italy
Ospedale Civile Maggiore Borgo Trento
Verona, , Italy
Hospital Univ. Dr. Jose Eleuterio Gonzalez
Monterrey, Nuevo León, Mexico
Investigacion en Salud y Metabolismo S.C
Chihuahua City, , Mexico
NZOZ ZDROWIE Osteo-Medic
Bialystok, , Poland
Poradnia Diabetologiczna SN ZOZ Lege Artis
Bialystok, , Poland
NS ZOZ Osrodek Diabetologiczny " Popula"
Bialystok, , Poland
Centrum Badan Klinicznych, PI House
Gdansk, , Poland
NZOZ Salvia s.c.
Katowice, , Poland
NZOZ Diab-Endo-Met
Krakow, , Poland
Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.
Lodz, , Poland
Gabinety Terpa
Lublin, , Poland
NZOZ Przychodnia Specjalistyczna MEDICA
Lublin, , Poland
Centrum Medyczne OMEDICA
Poznan, , Poland
Praktyka Lekarska
Poznan, , Poland
Nzoz Neuro - Kard
Poznan, , Poland
NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek
Ruda Śląska, , Poland
Centralny Szpital Kliniczny MSW
Warsaw, , Poland
Regionalna Poradnia Diabetologiczna
Wroclaw, , Poland
Research and Cardiovascular Corp.
Ponce, PR, Puerto Rico
Office: Dr. Luis Rivera Colon
San Juan, PR, Puerto Rico
Clinical Research Puerto Rico, Inc.
San Juan, , Puerto Rico
GCM Medical Group PSC
San Juan, , Puerto Rico
S. C. Grandmed S.R.L., Str.
Oradea, Bihor County, Romania
SC Gama Diamed SRL
Mangalia, Constanța County, Romania
Spitalul Judetean de Urgenta Satu Mare
Satu Mare, Jud Satu-Mare, Romania
CMI DNBM Dr. Pop Lavinia
Baia Mare, Maramureş, Romania
Cosamext SRL
Târgu Mureş, Mureș County, Romania
SC Diabmed Dr Popescu Alexandrina SRL
Ploieşti, Prahova, Romania
SC Dianutrilife Medica SRL
Ploieşti, Prahova, Romania
Centrul Medical Dr. Negrisanu
Timișoara, Timiș County, Romania
Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL
Brasov, , Romania
Cabinetul Medical Nicodiab SRL
Bucharest, , Romania
Easydiet SRL
Bucharest, , Romania
SC Nutrilife SRL
Bucharest, , Romania
SC Medcon SRL
Buzău, , Romania
Centrul Medical Unirea SRL
Cluj-Napoca, , Romania
Cabinet Medical Urodiamed S.R.L.
Craiova, , Romania
Milena Sante SRL
Galati, , Romania
SC Olimpia Med SRL
Iași, , Romania
Regional Clinical Hospital
Saratov, Russian Federation, Russia
Arkhangelsk Regional Clinical Hospital
Arkhangelsk, , Russia
Arkhangelsk the first city clinical hospital
Arkhangelsk, , Russia
Rostov State Medical University
Rostov-on-Don, , Russia
City Hospital of Saint Martyr Elizabeth
Saint Petersburg, , Russia
SPb GUZ "Diagnostic Center #85"
Saint Petersburg, , Russia
Human care s.r.o.
Košice, Slovak Republic, Slovakia
MediVet s.r.o.
Malacky, Slovak Republic, Slovakia
Areteus s.r.o.
Trebišov, Slovak Republic, Slovakia
Diacrin s.r.o.
Bratislava, , Slovakia
Noemis, s.r.o.
Nové Mesto nad Váhom, , Slovakia
FUNKYSTUFF s.r.o.
Nové Zámky, , Slovakia
MUDr. Jan Culak, s.r.o.
Prievidza, , Slovakia
DIA-MED CENTRUM s.r.o.
Púchov, , Slovakia
Tatratrial s.r.o.
Rožňava, , Slovakia
Hospital Infanta Luisa
Seville, Andalusia, Spain
Clinica Juaneda
Palma de Mallorca, Balearic Islands, Spain
Corporació Sanitaria Parc Tauli
Sabadell, Barcelona, Spain
Hospital Universitario Marques De Valdecilla
Santander, Cantabria, Spain
Hospital Universitario Quiron Madrid
Pozuelo de Alarcón, Madrid, Spain
Instituto de Ciencias medicas
Alicante, , Spain
Clinica San Pedro
Almería, , Spain
Centre Medico Teknon
Barcelona, , Spain
Hospital Clinico Universitario San Cecilio
Granada, , Spain
Virgen de Las Nieves
Granada, , Spain
Centro Especialidades San Jose Obrero (Barbarela)
Málaga, , Spain
Clinica Nuevas Tecnologias en Diabetes y Endocrinologia
Seville, , Spain
Hospital Universitario Virgen Macarena
Seville, , Spain
Policlinica Galileo
Teruel, , Spain
Chung Shan Medical University Hospital
Taichung, , Taiwan
Taichung Veterans General Hospital
Taichung, , Taiwan
Chi-Mei Medical Center
Tainan City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ferdinand KC, Dunn J, Nicolay C, Sam F, Blue EK, Wang H. Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes. Cardiovasc Diabetol. 2023 Mar 9;22(1):49. doi: 10.1186/s12933-023-01775-x.
Cox DA, Wang H, Nicolay C, Bethel MA. Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study. Diabetes Obes Metab. 2022 Sep;24(9):1770-1778. doi: 10.1111/dom.14762. Epub 2022 May 29.
Frias JP, Bonora E, Nevarez Ruiz L, Li YG, Yu Z, Milicevic Z, Malik R, Bethel MA, Cox DA. Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11). Diabetes Care. 2021 Mar;44(3):765-773. doi: 10.2337/dc20-1473. Epub 2021 Jan 4.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (AWARD-11)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H9X-MC-GBGL
Identifier Type: OTHER
Identifier Source: secondary_id
2017-003490-33
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
16877
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.